Your client picks up their own prescription at CVS multiple times a month. Now CVS will fill the pet prescription you wrote, at the same counter.
The Consensus Read: It's Just Another Channel
CVS announced it will fill pet prescriptions, parasiticides, dermatology products, pain management, cardiovascular drugs, and several other categories, at its stores. The obvious take: it's one more competitor in a field that already includes online pharmacies, big-box retailers, and mail-order services.
That reading is incomplete, and it misses what CVS is actually selling.
What CVS Has That Chewy and 1-800-PetMeds Don't
Traffic. A pet owner visits her veterinary practice once or a few times a year, according to Brakke Consulting's John Volk. She visits her drugstore multiple times a month. The pet medications will be subject to the same auto-refill and home-delivery services customers get with their own prescriptions, Volk notes.
The other advantage: many human drugs are already prescribed for pets, and those scripts are already being filled at the local pharmacy. For a significant share of pet owners, CVS won't be the first time they've picked up a pet prescription at a retail pharmacy, it will be the first time the pharmacy actively marketed the service and stocked veterinary-specific products.
Volk stopped at a large CVS in downtown Chicago last week. The pharmacist was aware of the program but had no training or information about a start date.
The Number That Changes the Equation
There are nearly 35,000 veterinary clinics and only 9,000 CVS stores, according to the source. On paper, practices outnumber the chain nearly four to one. But CVS doesn't need more locations, it needs more visits per location. If the program works, Walgreens will follow with its 8,000 stores. Volk's read: "You can bet real money" on that.
Both chains have been closing locations, Walgreens shuttered 1,200 stores last year, CVS about 300, and searching for new revenue streams to stabilize foot traffic. Pet meds are the test case. If they work, the model scales fast.
Who Benefits From You Believing This Is Small
CVS benefits if practices treat this as noise rather than a structural shift. Every month a clinic delays addressing its dispensing strategy is a month CVS can embed the behavior: client uses the same auto-refill service they already use for their own medications, and stops calling the clinic for refills. The revenue doesn't disappear overnight, it erodes one standing order at a time.
The other group that benefits: the corporate consolidators and suppliers watching this closely. If retail pharmacies capture dispensing margin, the math changes for practices that have relied on product revenue.
If your production bonus or practice valuation assumes clients fill scripts at your clinic, subscribe to VeterinaryPracticeNow.
The Risk in Our Own Take
We could be wrong. The program could fail to gain traction, or clients could stick with their veterinarian for reasons CVS can't replicate. Volk notes that the Chicago pharmacist he spoke with had no training yet, which suggests the rollout isn't uniform across all stores. If CVS doesn't push the program aggressively, signage, pharmacist training, customer education, it becomes just another undermarketed service that fades.
But the setup favors CVS. They have the auto-refill infrastructure and the monthly visit frequency. Practices have the prescription pad and the relationship. The question is whether the relationship is strong enough to override the convenience of filling the pet prescription at the same place the client already goes for their own medications.
What Changes Monday
If you dispense, you now compete with a chain that has the auto-refill infrastructure your clients already use for their own prescriptions. The play isn't to out-convenience CVS, aim instead to make the case for why filling at your clinic is worth the extra step, and to make that case before the client shifts the behavior.
For owner-veterinarians: if dispensing revenue has been covering overhead and CVS takes the recurring prescriptions, the P&L conversation is worth having this quarter, not after the trend is visible in your numbers.